EUVIMEDEUVIMED entdecken
Crossref

Gynecological carcinosarcomas: Overview and future perspectives

Laetitia Collet, Andrea María González López, Clémence Romeo, Pierre Méeus, Nicolas Chopin, Léa Rossi, Elise Rowinski, Anne-Agathe Serre, Corrinne Rannou, Adrien Buisson, Isabelle Treilleux, Isabelle Ray-Coquard

Bulletin du Cancer · 2023-11 · 110 (11) · 1215-1226

DOI: 10.1016/j.bulcan.2023.07.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin du Cancer, 2023-11. Verfasst von Laetitia Collet und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institut Jules-Bordet, Breast Cancer Translational Research Laboratory, Bruxelles, Belgium; Institut Jules-Bordet, Department of Medical Oncology, Br…. Hauptthemen laut MEDLINE: Uterine Neoplasms, Ovarian Neoplasms, Carcinosarcoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gynecologic carcinosarcoma (CS) are rare and aggressive tumors composed of high-grade carcinoma and sarcoma. Carcinosarcoma account for less than 5% of uterine and ovarian carcinoma and patients have poor outcome with a 5-year overall survival of less than 30%. In early-stage setting, the treatment mainstay is surgery and adjuvant chemoradiotherapy or adjuvant chemotherapy in uterine (UCS) and ovarian CS (OCS), respectively. In metastatic or advanced stage disease, chemotherapy is the rule with a lower response rate and poorer prognosis compared to other high-grade carcinomas. Although very few treatment options are available, CS are often excluded from the clinical trials precluding therapeutic improvement. However, recent molecular advances are paving the way for new therapeutic strategies. In the current proposal, we extensively review the uterine and ovarian carcinosarcomas including epidemiology, pathology, genomic landscape, as well as current therapies and future perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine NeoplasmsOvarian NeoplasmsCarcinosarcomaFemaleHumansChemotherapy, AdjuvantCarcinoma, Ovarian Epithelial

Stichwörter der Autor:innen

CarcinosarcomaMolecular landscapeRare gynecological tumorsSystemic therapy

Autor:innen und Institutionen

  • Institut Jules-Bordet, Breast Cancer Translational Research Laboratory, Bruxelles, Belgium; Institut Jules-Bordet, Department of Medical Oncology, Bruxelles, Belgium; Centre Leon-Berard, Department of Medical Oncology,…
  • University Hospital Foundation Alcorcon, Department of Medical Oncology, Madrid, Spain.
  • Centre Leon-Berard, Department of Medical Oncology, Lyon, France.
  • Centre Leon-Berard, Department of Surgery, Lyon, France.
  • Centre Leon-Berard, Department of Radiotherapy, Lyon, France.
  • Centre Leon-Berard, Department of Radiology, Lyon, France.

Zitieren

APA

Collet, L., González López, A. M., Romeo, C., Méeus, P., Chopin, N., Rossi, L., Rowinski, E., Serre, A. A., Rannou, C., Buisson, A., Treilleux, I., & Ray-Coquard, I. (2023). Gynecological carcinosarcomas: Overview and future perspectives. Bulletin du Cancer, 110(11), 1215-1226. https://doi.org/10.1016/j.bulcan.2023.07.005

Vancouver

Collet L, González López AM, Romeo C, Méeus P, Chopin N, Rossi L, et al. Gynecological carcinosarcomas: Overview and future perspectives. Bulletin du Cancer. 2023;110(11):1215-1226. doi:10.1016/j.bulcan.2023.07.005

BibTeX
@article{Collet2023,
  author = {Collet, Laetitia and González López, Andrea María and Romeo, Clémence and Méeus, Pierre and Chopin, Nicolas and Rossi, Léa and Rowinski, Elise and Serre, Anne-Agathe and Rannou, Corrinne and Buisson, Adrien and Treilleux, Isabelle and Ray-Coquard, Isabelle},
  title = {Gynecological carcinosarcomas: Overview and future perspectives},
  journal = {Bulletin du Cancer},
  year = {2023},
  volume = {110},
  number = {11},
  pages = {1215--1226},
  doi = {10.1016/j.bulcan.2023.07.005}
}
Kostenlos starten →